Speakers

Emerson

Bronze Sponsor & Exhibitor

Emerson is the leading supplier of automation solutions to the Life Sciences Industry, with automation expertise and technologies to solve your greatest cGMP manufacturing challenges.  Accelerate time to market for new therapeutics and increasing efficiencies for CGT manufacturing techniques.  Our consultants can help create effective solutions to improve inventory management, eliminate variability, and deliver cost effective compliance with repeatable production.  Ask our experts how our trusted brands such as DeltaV, Syncade, Rosemount, ASCO and more can empower your single use production.  From design to implementation, and start-up to on-going optimization, rely on Emerson to stay competitive in a global economy. 

 

Speakers

ARMI | BioFabUSA

Bronze Sponsor

The Advanced Regenerative Manufacturing Institute (ARMI), headquartered in Manchester, NH, is an organization funded by the United States Department of Defense. ARMI’s mission is to make practical the scalable manufacturing of engineered tissues and tissue-related technologies, to benefit existing industries and grow new ones. ARMI brings together a consortium of over 170 partners from across industry, government, academia, and the non-profit sector to develop next-generation manufacturing processes and technologies for cells, tissues, and organs. 

Speakers

Novo Nordisk

Bronze Sponsor & Exhibitor
Speakers

Azenta Life Sciences

Bronze Sponsor & Exhibitor

Azenta Life Sciences provides unrivaled sample exploration and management solutions to help our customers accelerate discovery, development, and delivery to bring impactful breakthroughs and therapies to market faster. We are the global leader in automated compound management for drug discovery, biological storage, and sample processing solutions. Azenta understands the importance of sample integrity and provides a comprehensive range of solutions across our leading capabilities of genomic services, sample repository services (SRS), consumables and instruments, data management and informatics, sample sourcing, and automated ultra-cold storage. 

Speakers

Entegris

Bronze Sponsor & Exhibitor
Speakers

Ori Biotech

Bronze Sponsor
Speakers

Cook MyoSite

Bronze Sponsor

Cook MyoSite was formed in 2002 to guide the Cook Group organization into the expanding world of cellular technologies. Today, we are dedicated to the development and subsequent commercialization of technology related to the collection, selection, and expansion of human skeletal muscle cells for the treatment of various disorders. 

We are currently investigating autologous muscle derived cells, or AMDC, a personalized, regenerative cell therapy product. AMDC is created from muscle progenitor cells that are isolated from human adult muscle and are theorized to engraft into existing dysfunctional or weakened target tissue to improve muscle function. 

AMDC-USR is an investigational product that is injected into the urinary sphincter and is hypothesized to reduce the number of incontinence episodes in women with stress urinary incontinence. 

The AMDC technology is also being clinically investigated for fecal incontinence, underactive bladder, and tongue dysphagia.  

Speakers

Humacyte

Bronze Sponsor & Exhibitor

Humacyte, Inc., (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte’s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Pre-clinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte’s HAVs were the first product to receive the FDA’s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation and received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense. For more information, visit www.Humacyte.com. 

Speakers

Buchanan Ingersoll Rooney

Bronze Sponsor

Buchanan Life Sciences offers a rare and comprehensive mix of FDA Regulatory, Intellectual Property, Litigation and Government Relations services delivered through one seamless team. We counsel clients on the full range of issues that arise during the product lifecycle, from idea conception to commercialization. Our clients, which include leading pharmaceutical companies, wholesalers and distributors, retailers, industry trade associations and leading research institutions, trust us with their most challenging issues. Buchanan’s team has decades of experience working with Congress, FDA, DOJ, FTC and the USPTO. Our deep understanding of the legal and technical issues impacting the life sciences industry allows us to develop effective approaches to addressing our clients’ legal and business objectives.